These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6602035)

  • 1. Immune T cells prevent bacteroides fragilis abscesses.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    Curr Surg; 1983; 40(2):123-6. PubMed ID: 6602035
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis.
    Shapiro ME; Kasper DL; Zaleznik DF; Spriggs S; Onderdonk AB; Finberg RW
    J Immunol; 1986 Jul; 137(1):341-6. PubMed ID: 3486915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses.
    Crabb JH; Finberg R; Onderdonk AB; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S178-84. PubMed ID: 2406870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses.
    Zaleznik DF; Finberg RW; Shapiro ME; Onderdonk AB; Kasper DL
    J Clin Invest; 1985 Mar; 75(3):1023-7. PubMed ID: 2579976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune mechanisms in the prevention of intra-abdominal abscess formation.
    Kasper DL; Finberg RF; Crabb J; Onderdonk AB
    Scand J Infect Dis Suppl; 1989; 62():29-34. PubMed ID: 2587962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good and laudable pus.
    Gorbach SL
    J Clin Invest; 1995 Dec; 96(6):2545. PubMed ID: 8675616
    [No Abstract]   [Full Text] [Related]  

  • 9. Preexposure of the peritoneum to live bacteria increases later mixed intraabdominal abscess formation and delays mortality.
    Sawyer RG; Adams RB; Spengler MD; Pruett TL
    J Infect Dis; 1991 Mar; 163(3):664-7. PubMed ID: 1995742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zwitterionic polysaccharides stimulate T cells with no preferential V beta usage and promote anergy, resulting in protection against experimental abscess formation.
    Stingele F; Corthésy B; Kusy N; Porcelli SA; Kasper DL; Tzianabos AO
    J Immunol; 2004 Feb; 172(3):1483-90. PubMed ID: 14734725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro.
    Brubaker JO; Li Q; Tzianabos AO; Kasper DL; Finberg RW
    J Immunol; 1999 Feb; 162(4):2235-42. PubMed ID: 9973499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies to Bacteroides antigens in the blood serum].
    Tyshko AG; Fal' MM; Fal' NI; Marchenko NN; Smol'nikova LI
    Vrach Delo; 1984 Feb; (2):111-2. PubMed ID: 6144208
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of intra-abdominal abscesses with fibrinolytic agents.
    Rosenthal GA; Quinto J; Kao J; Rotstein OD
    Can J Surg; 1988 Mar; 31(2):98-100. PubMed ID: 3127033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteroides fragilis-stimulated interleukin-10 contains expanding disease.
    Cohen-Poradosu R; McLoughlin RM; Lee JC; Kasper DL
    J Infect Dis; 2011 Aug; 204(3):363-71. PubMed ID: 21742834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of T lymphocytes in liver abscess formation by Bacteroides fragilis in mice.
    Chung DR; Park HR; Park CG; Hwang ES; Cha CY
    Infect Immun; 2011 Jun; 79(6):2234-40. PubMed ID: 21444668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
    Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of glucan and cefoxitin in prevention of murine abscess.
    Hull CC; Stellato TA; Rhodes RS; Galloway P; Hawkins NL
    Curr Surg; 1986; 43(5):416-8. PubMed ID: 3533446
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
    Brook I
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S376-7. PubMed ID: 7548603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.